주식/증권 📉 부정적

Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial

Yahoo Finance 09/08/2026 03:17:00 PM 3회

요약

NYXH initiates its U.S. BREATHE study with the first Genio implant, advancing long-term clinical evidence following FDA approval.

원문 기사 보기

관련 뉴스

U.S. builds AI infrastructure while Europe leads in adoption, Apollo says

Fermi surges after signing credit support deal with AMD for Texas AI project

Earnings Snapshot: Citigroup tops Q3 top and bottom line estimates driven by services and markets growth

Mesa Laboratories announces $9.3M cost-savings plan

뉴스 목록으로